US3654090A
(en)
|
1968-09-24 |
1972-04-04 |
Organon |
Method for the determination of antigens and antibodies
|
NL154598B
(nl)
|
1970-11-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
|
US4016043A
(en)
|
1975-09-04 |
1977-04-05 |
Akzona Incorporated |
Enzymatic immunological method for the determination of antigens and antibodies
|
US4265823A
(en)
|
1979-01-04 |
1981-05-05 |
Robert E. Kosinski |
Aurothiosteroids
|
US4737462A
(en)
|
1982-10-19 |
1988-04-12 |
Cetus Corporation |
Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
|
US4518584A
(en)
|
1983-04-15 |
1985-05-21 |
Cetus Corporation |
Human recombinant interleukin-2 muteins
|
JPS60174629A
(ja)
|
1984-02-20 |
1985-09-07 |
Mitsubishi Monsanto Chem Co |
二軸延伸されたポリアミドフイルムの製造方法
|
US4699880A
(en)
|
1984-09-25 |
1987-10-13 |
Immunomedics, Inc. |
Method of producing monoclonal anti-idiotype antibody
|
US4800159A
(en)
|
1986-02-07 |
1989-01-24 |
Cetus Corporation |
Process for amplifying, detecting, and/or cloning nucleic acid sequences
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
US4704692A
(en)
|
1986-09-02 |
1987-11-03 |
Ladner Robert C |
Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
|
AU600575B2
(en)
|
1987-03-18 |
1990-08-16 |
Sb2, Inc. |
Altered antibodies
|
US5284931A
(en)
|
1987-05-04 |
1994-02-08 |
Dana Farber Cancer Institute |
Intercellular adhesion molecules, and their binding ligands
|
US4935234A
(en)
|
1987-06-11 |
1990-06-19 |
Dana-Farber Cancer Institute |
Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
|
US5219997A
(en)
|
1987-07-06 |
1993-06-15 |
Dana-Farber Cancer Institute |
Monoclonal antibody which inhibits the adhesion functions of the β integrin, CR3
|
US5114842A
(en)
|
1987-07-08 |
1992-05-19 |
The Scripps Research Institute |
Peptides and antibodies that inhibit platelet adhesion
|
US4925572A
(en)
|
1987-10-20 |
1990-05-15 |
Pall Corporation |
Device and method for depletion of the leukocyte content of blood and blood components
|
US4880548A
(en)
|
1988-02-17 |
1989-11-14 |
Pall Corporation |
Device and method for separating leucocytes from platelet concentrate
|
US5147637A
(en)
|
1988-06-07 |
1992-09-15 |
The Rockefeller University |
Method of inhibiting the influx of leukocytes into organs during sepsis or other trauma
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
US5235049A
(en)
|
1989-01-24 |
1993-08-10 |
Molecular Therapeutics, Inc. |
Nucleic acid sequences encoding a soluble molecule (SICAM-1) related to but distinct from ICAM-1
|
US5002873A
(en)
|
1989-03-17 |
1991-03-26 |
Fred Hutchinson Cancer Research Center |
DNA sequence encoding a lymphocyte adhesion receptor for high endothelium
|
US5091302A
(en)
|
1989-04-27 |
1992-02-25 |
The Blood Center Of Southeastern Wisconsin, Inc. |
Polymorphism of human platelet membrane glycoprotein iiia and diagnostic and therapeutic applications thereof
|
US5272263A
(en)
|
1989-04-28 |
1993-12-21 |
Biogen, Inc. |
DNA sequences encoding vascular cell adhesion molecules (VCAMS)
|
US5137806A
(en)
|
1989-12-11 |
1992-08-11 |
Board Of Regents, The University Of Texas System |
Methods and compositions for the detection of sequences in selected DNA molecules
|
US5264554A
(en)
|
1990-01-19 |
1993-11-23 |
The Blood Center Of Southeastern Wisconsin, Inc. |
Platelet cell adhesion molecule and variants thereof
|
GB9009548D0
(en)
|
1990-04-27 |
1990-06-20 |
Celltech Ltd |
Chimeric antibody and method
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
US5210015A
(en)
|
1990-08-06 |
1993-05-11 |
Hoffman-La Roche Inc. |
Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
|
WO1992002819A2
(en)
|
1990-08-10 |
1992-02-20 |
The Regents Of The University Of California |
Assay for ulcerative colitis and primary sclerosing cholangitis
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
ATE158021T1
(de)
|
1990-08-29 |
1997-09-15 |
Genpharm Int |
Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5085318A
(en)
|
1990-11-19 |
1992-02-04 |
Leverick Kathy L |
Secured disc folder
|
US6277969B1
(en)
|
1991-03-18 |
2001-08-21 |
New York University |
Anti-TNF antibodies and peptides of human tumor necrosis factor
|
RO115415B1
(ro)
|
1991-06-11 |
2000-02-28 |
Center For Blood Research, Inc. |
Moleculă-3 de adeziune intercelulară (icam-3), moleculă adn recombinant care o codifică, anticorpi ai acesteia, metodă de producere a celulei hibridoma, metode de modulare a funcţiilor biologice, de suprimare, identificare, diagnoză şi compoziţii farmaceutice
|
LU91067I2
(fr)
|
1991-06-14 |
2004-04-02 |
Genentech Inc |
Trastuzumab et ses variantes et dérivés immuno chimiques y compris les immotoxines
|
US5227369A
(en)
|
1991-07-11 |
1993-07-13 |
The Regents Of The University Of California |
Compositions and methods for inhibiting leukocyte adhesion to cns myelin
|
US5234810A
(en)
|
1991-09-20 |
1993-08-10 |
The United States Of America As Represented By The Secretary Of Agriculture |
Diagnostic assays for genetic mutations associated with bovine leukocyte adhesion deficiency
|
WO1993007485A1
(en)
|
1991-10-10 |
1993-04-15 |
The Regents Of The University Of California |
Rare immunoglobulin framework regions associated with human disease
|
US5885793A
(en)
|
1991-12-02 |
1999-03-23 |
Medical Research Council |
Production of anti-self antibodies from antibody segment repertoires and displayed on phage
|
GB9126918D0
(en)
|
1991-12-19 |
1992-02-19 |
Univ London |
Members of specific binding pairs;methods of their making and using
|
US5236081A
(en)
|
1992-01-31 |
1993-08-17 |
Shape Inc. |
Compact disc package
|
ATE161192T1
(de)
|
1992-08-21 |
1998-01-15 |
Genentech Inc |
Verfahren zur behandlung einer durch lfa-1 vermittelten störung
|
US5263743A
(en)
|
1992-09-25 |
1993-11-23 |
Pharmagraphics, Inc. |
Package label
|
WO1994014467A1
(en)
|
1992-12-29 |
1994-07-07 |
Genentech, Inc. |
Treatment of inflammatory bowel disease with ifn-gamma inhibitors
|
US5830675A
(en)
|
1993-03-10 |
1998-11-03 |
Cedars-Sinai Medical Center |
Methods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis, primary sclerosing cholangitis, or type 1 autoimmune hepatitis
|
DK0615129T3
(da)
|
1993-03-10 |
2000-08-07 |
Cedars Sinai Medical Center |
Fremgangsmåder til selektiv påvisning af perinukleært anti-neutrophilt cytoplasmatisk antistof fra ulcerativ colitis eller
|
GB9307503D0
(en)
|
1993-04-13 |
1993-06-02 |
Kodak Ltd |
Method of making a photographic developer solution
|
GB9325182D0
(en)
|
1993-12-08 |
1994-02-09 |
T Cell Sciences Inc |
Humanized antibodies or binding proteins thereof specific for t cell subpopulations exhibiting select beta chain variable regions
|
US5681699A
(en)
|
1994-02-11 |
1997-10-28 |
Cedars-Sinai Medical Center |
Methods of diagnosing ulcerative colitis and Crohn's disease
|
ATE207967T1
(de)
|
1994-05-17 |
2001-11-15 |
Cedars Sinai Medical Center |
Verfahren zum screening für die erkrankung crohn durch die verwendung von tnf-mikrosatelliten allelen
|
US5494920A
(en)
|
1994-08-22 |
1996-02-27 |
Eli Lilly And Company |
Methods of inhibiting viral replication
|
US5491063A
(en)
|
1994-09-01 |
1996-02-13 |
Hoffmann-La Roche Inc. |
Methods for in-solution quenching of fluorescently labeled oligonucleotide probes
|
US5691151A
(en)
|
1994-10-07 |
1997-11-25 |
Regents Of University Of California |
Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca
|
US20030198640A1
(en)
|
1994-11-07 |
2003-10-23 |
Human Genome Sciences, Inc. |
Methods and compositions for treating inflammatory bowel diseases relating to human tumor necrosis factor-gamma-beta
|
US20030129189A1
(en)
|
1994-11-07 |
2003-07-10 |
Guo-Liang Yu |
Tumor necrosis factor-gamma
|
US7820798B2
(en)
|
1994-11-07 |
2010-10-26 |
Human Genome Sciences, Inc. |
Tumor necrosis factor-gamma
|
WO2000066608A1
(en)
|
1999-04-30 |
2000-11-09 |
Human Genome Sciences, Inc. |
Tumor necrosis factor-gamma
|
US7597886B2
(en)
|
1994-11-07 |
2009-10-06 |
Human Genome Sciences, Inc. |
Tumor necrosis factor-gamma
|
US6599719B2
(en)
|
1994-11-07 |
2003-07-29 |
Human Genome Sciences, Inc. |
Nucleic acid molecules encoding tumor necrosis factor-gamma-alpha
|
US6824767B2
(en)
|
1994-11-07 |
2004-11-30 |
Human Genome Sciences, Inc. |
Tumor necrosis factor-gamma
|
AU708972B2
(en)
|
1994-11-07 |
1999-08-19 |
Human Genome Sciences, Inc. |
Tumor necrosis factor-gamma
|
JPH08248832A
(ja)
|
1995-03-06 |
1996-09-27 |
Mita Ind Co Ltd |
画像形成装置
|
US5518488A
(en)
|
1995-03-20 |
1996-05-21 |
Schluger; Allen |
CD holder of cardboard and method of construction
|
US5607879A
(en)
|
1995-06-28 |
1997-03-04 |
Taiwan Semiconductor Manufacturing Company Ltd. |
Method for forming buried plug contacts on semiconductor integrated circuits
|
US6828422B1
(en)
|
1995-08-18 |
2004-12-07 |
Morphosys Ag |
Protein/(poly)peptide libraries
|
JP4436457B2
(ja)
|
1995-08-18 |
2010-03-24 |
モルフォシス アイピー ゲーエムベーハー |
蛋白質/(ポリ)ペプチドライブラリー
|
US6632976B1
(en)
|
1995-08-29 |
2003-10-14 |
Kirin Beer Kabushiki Kaisha |
Chimeric mice that are produced by microcell mediated chromosome transfer and that retain a human antibody gene
|
US5840300A
(en)
|
1995-09-11 |
1998-11-24 |
Trustees Of The University Of Pennsylvania |
Methods and compositions comprising single chain recombinant antibodies
|
US5942390A
(en)
|
1996-01-12 |
1999-08-24 |
Cedars-Sinai Medical Center |
Method of diagnosing predisposition for ulcerative colitis in Jewish population by detection of interleukin-1 receptor antagonist polymorphism
|
US6713061B1
(en)
|
1996-03-12 |
2004-03-30 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
US7357927B2
(en)
|
1996-03-12 |
2008-04-15 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
US5590769A
(en)
|
1996-03-20 |
1997-01-07 |
Lin; Shi-Ping |
Individual CD case
|
EP0938320B2
(en)
|
1996-03-26 |
2014-06-18 |
Michael S. Kopreski |
Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer
|
US6025539A
(en)
|
1996-04-09 |
2000-02-15 |
Mayo Foundation For Medical Education And Research |
IL-5 transgenic mouse
|
US5916748A
(en)
|
1996-04-12 |
1999-06-29 |
Cedars-Sinai Medical Center |
Method of diagnosing a clinical subtype of crohn's disease with features of ulcerative colitis
|
AU2438397A
(en)
|
1996-04-12 |
1997-11-07 |
Cedars-Sinai Medical Center |
Methods of determining the risk of pouchitis development
|
US6074835A
(en)
|
1996-04-12 |
2000-06-13 |
Regents Of The Univ. Of California |
Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using histone H1
|
US5874233A
(en)
|
1996-04-12 |
1999-02-23 |
Cedars-Sinai Medical Center |
Methods of diagnosing a clinical subtype of Crohn's disease with features of ulcerative colitis
|
US5683698A
(en)
|
1996-08-02 |
1997-11-04 |
New England Deaconess Hospital |
Formulation for alleviating symptoms associated with arthritis
|
JPH1078528A
(ja)
|
1996-09-03 |
1998-03-24 |
Fujitsu Ltd |
光合分波器及び波長分割多重モジュール
|
US6034102A
(en)
|
1996-11-15 |
2000-03-07 |
Pfizer Inc |
Atherosclerosis treatment
|
US6114395A
(en)
|
1996-11-15 |
2000-09-05 |
Pfizer Inc. |
Method of treating atherosclerosis
|
US7514232B2
(en)
|
1996-12-06 |
2009-04-07 |
Becton, Dickinson And Company |
Method for detecting T cell response to specific antigens in whole blood
|
US20040013664A1
(en)
|
1997-01-14 |
2004-01-22 |
Gentz Reiner L. |
Tumor necrosis factor receptors 6 alpha & 6 beta
|
CA2277925A1
(en)
|
1997-01-14 |
1998-07-16 |
Human Genome Sciences, Inc. |
Tumor necrosis factor receptors 6.alpha. and 6.beta.
|
US7285267B2
(en)
|
1997-01-14 |
2007-10-23 |
Human Genome Sciences, Inc. |
Tumor necrosis factor receptors 6α & 6β
|
US6197928B1
(en)
|
1997-03-14 |
2001-03-06 |
The Regents Of The University Of California |
Fluorescent protein sensors for detection of analytes
|
US6183951B1
(en)
|
1997-04-11 |
2001-02-06 |
Prometheus Laboratories, Inc. |
Methods of diagnosing clinical subtypes of crohn's disease with characteristic responsiveness to anti-Th1 cytokine therapy
|
US5968741A
(en)
|
1997-04-11 |
1999-10-19 |
Cedars-Sinai Medical Center |
Methods of diagnosing a medically resistant clinical subtype of ulcerative colitis
|
US20030129215A1
(en)
|
1998-09-24 |
2003-07-10 |
T-Ram, Inc. |
Medical devices containing rapamycin analogs
|
DK1034298T3
(da)
|
1997-12-05 |
2012-01-30 |
Scripps Research Inst |
Humanisering af murint antistof
|
US6297367B1
(en)
|
1997-12-30 |
2001-10-02 |
Chiron Corporation |
Polynucleotide encoding TNFL1
|
US20020006613A1
(en)
|
1998-01-20 |
2002-01-17 |
Shyjan Andrew W. |
Methods and compositions for the identification and assessment of cancer therapies
|
US6607879B1
(en)
|
1998-02-09 |
2003-08-19 |
Incyte Corporation |
Compositions for the detection of blood cell and immunological response gene expression
|
EP1071458A4
(en)
|
1998-03-13 |
2005-02-16 |
Dana Farber Cancer Inst Inc |
HUMANIZED ANTIBODIES AND ITS USES
|
US5947281A
(en)
|
1998-07-06 |
1999-09-07 |
Kaneff; Mitchell S. |
Unfolding disc holder
|
US20050123938A1
(en)
|
1999-01-06 |
2005-06-09 |
Chondrogene Limited |
Method for the detection of osteoarthritis related gene transcripts in blood
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
US7368527B2
(en)
|
1999-03-12 |
2008-05-06 |
Human Genome Sciences, Inc. |
HADDE71 polypeptides
|
CA2267481A1
(en)
|
1999-03-30 |
2000-09-30 |
Gabriel Pulido-Cejudo |
Critical interdependency: from the role of estrogen on breast cancer to the susceptibility of women towards hiv infection
|
US6539374B2
(en)
|
1999-06-03 |
2003-03-25 |
Microsoft Corporation |
Methods, apparatus and data structures for providing a uniform representation of various types of information
|
KR20020016833A
(ko)
|
1999-06-15 |
2002-03-06 |
뉴트리-로직스, 인크. |
발병 감소에 유용한 영양 제제, 관련 치료 방법 및 성분스크리닝 방법
|
US6692916B2
(en)
|
1999-06-28 |
2004-02-17 |
Source Precision Medicine, Inc. |
Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
|
WO2001002588A2
(en)
|
1999-07-02 |
2001-01-11 |
Morphosys Ag |
Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests
|
US20030204075A9
(en)
|
1999-08-09 |
2003-10-30 |
The Snp Consortium |
Identification and mapping of single nucleotide polymorphisms in the human genome
|
US6376176B1
(en)
|
1999-09-13 |
2002-04-23 |
Cedars-Sinai Medical Center |
Methods of using a major histocompatibility complex class III haplotype to diagnose Crohn's disease
|
US6762042B2
(en)
|
1999-12-09 |
2004-07-13 |
Merck & Co., Inc. |
DNA molecules encoding human NHL a DNA helicase
|
AU2258601A
(en)
|
1999-12-10 |
2001-06-18 |
Ellipsis Biotherapeutics Corporation |
Ibd-related polymorphisms
|
US6869762B1
(en)
|
1999-12-10 |
2005-03-22 |
Whitehead Institute For Biomedical Research |
Crohn's disease-related polymorphisms
|
CA2395295A1
(en)
|
2000-01-31 |
2001-08-02 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins and antibodies
|
US20020165137A1
(en)
|
2000-01-31 |
2002-11-07 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
US7135303B2
(en)
|
2000-02-28 |
2006-11-14 |
The United States Of America As Represented By The Department Of Health And Human Services |
Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding
|
US6348316B1
(en)
|
2000-04-12 |
2002-02-19 |
Cedars-Sinai Medical Center |
Genetic testing for determining the risk of pouchitis development
|
US20110131679A2
(en)
|
2000-04-19 |
2011-06-02 |
Thomas La Rosa |
Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
|
CA2408935A1
(en)
|
2000-05-12 |
2001-11-15 |
Halina Offner |
Method of treating immune pathologies with low dose estrogen
|
US6972187B2
(en)
|
2000-05-12 |
2005-12-06 |
Millennium Pharmaceuticals, Inc. |
OAT5 molecules and uses therefor
|
US7138237B1
(en)
|
2000-05-19 |
2006-11-21 |
Cedars-Sinai Medical Center |
Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen
|
US6571638B2
(en)
|
2000-06-30 |
2003-06-03 |
Sawtek, Inc. |
Surface-acoustic-wave pressure sensor and associated methods
|
AU2001277857A1
(en)
|
2000-07-07 |
2002-01-21 |
Human Genome Sciences, Inc. |
Tumor necrosis factor-gamma
|
JP2004525605A
(ja)
|
2000-08-04 |
2004-08-26 |
ルードヴィヒ インスティテュート フォー キャンサー リサーチ |
抑制遺伝子
|
US20020019837A1
(en)
|
2000-08-11 |
2002-02-14 |
Balnaves James A. |
Method for annotating statistics onto hypertext documents
|
US6824989B1
(en)
|
2000-09-01 |
2004-11-30 |
Upstate Biotechnology, Inc. |
Recombinant monoclonal antibody to phosphotyrosine-containing proteins
|
US6812339B1
(en)
|
2000-09-08 |
2004-11-02 |
Applera Corporation |
Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
|
US20070037165A1
(en)
|
2000-09-08 |
2007-02-15 |
Applera Corporation |
Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
|
US20020048566A1
(en)
|
2000-09-14 |
2002-04-25 |
El-Deiry Wafik S. |
Modulation of cellular apoptosis and methods for treating cancer
|
WO2002028999A2
(en)
|
2000-10-03 |
2002-04-11 |
Gene Logic, Inc. |
Gene expression profiles in granulocytic cells
|
USH2191H1
(en)
|
2000-10-24 |
2007-06-05 |
Snp Consortium |
Identification and mapping of single nucleotide polymorphisms in the human genome
|
WO2002034912A1
(fr)
|
2000-10-24 |
2002-05-02 |
New Ind Res Organization |
Genomes participant a l'arthrite rhumatoide, procede de diagnostic de celle-ci, procede d'evaluation de la possibilite d'apparition de celle-ci, kit de diagnostic et methode et remedes therapeutiques destines a l'ar
|
AU2002243415B2
(en)
|
2000-10-30 |
2007-05-24 |
Regents Of The University Of Michigan |
Nod2 nucleic acids and proteins
|
US7892730B2
(en)
|
2000-12-22 |
2011-02-22 |
Sagres Discovery, Inc. |
Compositions and methods for cancer
|
US7820447B2
(en)
|
2000-12-22 |
2010-10-26 |
Sagres Discovery Inc. |
Compositions and methods for cancer
|
US20040072154A1
(en)
|
2000-12-22 |
2004-04-15 |
Morris David W. |
Novel compositions and methods for cancer
|
US20030092019A1
(en)
|
2001-01-09 |
2003-05-15 |
Millennium Pharmaceuticals, Inc. |
Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
|
WO2003008583A2
(en)
|
2001-03-02 |
2003-01-30 |
Sagres Discovery |
Novel compositions and methods for cancer
|
US20020182274A1
(en)
|
2001-03-21 |
2002-12-05 |
Kung-Ming Lu |
Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
|
US20050143333A1
(en)
|
2001-05-18 |
2005-06-30 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (SINA)
|
US20050261219A1
(en)
|
2001-05-18 |
2005-11-24 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)
|
US20050182007A1
(en)
|
2001-05-18 |
2005-08-18 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (SINA)
|
US6905827B2
(en)
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
CA2391711A1
(en)
|
2001-06-26 |
2002-12-26 |
University Of Guelph |
Non-radioactive assay of lipopolysaccharide kinases
|
US20040142325A1
(en)
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
US20070082337A1
(en)
|
2004-01-27 |
2007-04-12 |
Compugen Ltd. |
Methods of identifying putative gene products by interspecies sequence comparison and biomolecular sequences uncovered thereby
|
CA2460621A1
(en)
|
2001-09-19 |
2003-03-27 |
Nuvelo, Inc. |
Novel nucleic acids and polypeptides
|
GB0124315D0
(en)
|
2001-10-10 |
2001-11-28 |
Oxagen Ltd |
Inflammatory bowel disease
|
US6964850B2
(en)
|
2001-11-09 |
2005-11-15 |
Source Precision Medicine, Inc. |
Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
|
CA2467629A1
(en)
|
2001-11-20 |
2003-05-30 |
Oncomedx, Inc. |
Methods for evaluating drug-resistance gene expression in the cancer patient
|
US7871619B2
(en)
|
2001-11-30 |
2011-01-18 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
US20070237770A1
(en)
|
2001-11-30 |
2007-10-11 |
Albert Lai |
Novel compositions and methods in cancer
|
ES2405790T3
(es)
|
2001-12-17 |
2013-06-03 |
Corixa Corporation |
Composiciones y métodos para la terapia y el diagnóstico de enfermedad inflamatoria del intestino
|
FI20020078A
(fi)
|
2002-01-15 |
2003-07-16 |
Danisco |
Immuunijärjestelmän stimulointi polydextroosilla
|
US6878518B2
(en)
|
2002-01-22 |
2005-04-12 |
The Trustees Of The University Of Pennsylvania |
Methods for determining steroid responsiveness
|
US20070015271A1
(en)
|
2002-04-04 |
2007-01-18 |
Rosen Craig A |
Human secreted proteins
|
US7745180B2
(en)
|
2002-04-24 |
2010-06-29 |
Hitachi Chemical Co., Ltd. |
Device and method for high-throughput quantification of mRNA from whole blood
|
NZ566263A
(en)
|
2002-05-24 |
2009-09-25 |
Millennium Pharm Inc |
CCR9 inhibitors and methods of use thereof
|
AU2003232872A1
(en)
|
2002-05-27 |
2003-12-12 |
Ostergotlands Lans Landsting |
Method for determining immune system affecting compounds
|
US20040053263A1
(en)
|
2002-08-30 |
2004-03-18 |
Abreu Maria T. |
Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease
|
TW200409759A
(en)
|
2002-09-25 |
2004-06-16 |
Wyeth Corp |
Substituted 4-(indazol-3-yl)phenols
|
DE60336406D1
(de)
|
2002-10-16 |
2011-04-28 |
Purdue Pharma Lp |
Antikörper, die an zellassoziiertes ca 125/0722p binden, und verfahren zu deren anwendung
|
US20070254850A1
(en)
|
2002-10-30 |
2007-11-01 |
Judy Lieberman |
Methods for Treating and Preventing Apoptosis-Related Diseases Using Rna Interfering Agents
|
WO2004048600A2
(en)
|
2002-11-22 |
2004-06-10 |
Emory University |
Diagnostic tests and methods for diagnosing inflammatory bowel disease
|
CA2507080C
(en)
|
2002-11-27 |
2015-01-06 |
Biogen Idec Ma Inc. |
Humanized antibodies against monocyte chemotactic proteins
|
AU2003303384A1
(en)
|
2002-12-23 |
2004-07-22 |
Schering Corporation |
Uses of mammalian cytokine; related reagents
|
AU2002953533A0
(en)
|
2002-12-24 |
2003-01-16 |
Arthron Limited |
Fc receptor modulating compounds and compositions
|
US20070020637A1
(en)
|
2003-01-21 |
2007-01-25 |
Research Association For Biotechnology |
Full-length cDNA
|
US8071304B2
(en)
|
2003-04-05 |
2011-12-06 |
The Johns Hopkins University |
Methods for detecting a polymorphism in the NFKB1 gene promoter
|
US7662569B2
(en)
|
2003-04-11 |
2010-02-16 |
Cedars-Sinai Medical Center |
Methods of assessing Crohn's disease patient phenotype by I2 serologic response
|
WO2004109288A1
(en)
|
2003-06-06 |
2004-12-16 |
Astrazeneca Ab |
Method for diagnosing inflammatory bowel disease
|
WO2005018571A2
(en)
|
2003-08-20 |
2005-03-03 |
University Of Miami |
Compositions and methods for treating inflammatory lung disease
|
WO2005018436A2
(en)
|
2003-08-26 |
2005-03-03 |
The Trustees Of Boston University |
Methods for the diagnosis, prognosis and treatment of metabolic syndrome
|
WO2005030133A2
(en)
|
2003-09-22 |
2005-04-07 |
Yale University |
Treatment with agonists of toll-like receptors
|
US20070161003A1
(en)
|
2003-09-29 |
2007-07-12 |
Morris David W |
Novel therapeutic targets in cancer
|
US20050101889A1
(en)
|
2003-11-06 |
2005-05-12 |
Freeman Gary A. |
Using chest velocity to process physiological signals to remove chest compression artifacts
|
US20070054278A1
(en)
|
2003-11-18 |
2007-03-08 |
Applera Corporation |
Polymorphisms in nucleic acid molecules encoding human enzyme proteins, methods of detection and uses thereof
|
AU2004294526A1
(en)
|
2003-12-03 |
2005-06-16 |
Glycominds, Ltd |
Method for diagnosing diseases based on levels of anti-glycan antibodies
|
JP2008504803A
(ja)
|
2004-01-09 |
2008-02-21 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
遺伝子発現の細胞型特異的パターン
|
EP1755673B1
(en)
|
2004-04-12 |
2014-07-23 |
MedImmune, LLC |
Anti-il-9 antibody formulations and uses thereof
|
WO2005114469A1
(fr)
|
2004-04-19 |
2005-12-01 |
Kartoo Sa |
Procede et dispositif de recherche avec conservation personnalisee des resultats
|
US7759079B2
(en)
|
2004-05-13 |
2010-07-20 |
Prometheus Laboratories Inc. |
Methods of diagnosing inflammatory bowel disease
|
US20060154276A1
(en)
|
2004-05-13 |
2006-07-13 |
Prometheus Laboratories Inc. |
Methods of diagnosing inflammatory bowel disease
|
US7407753B2
(en)
|
2004-05-24 |
2008-08-05 |
Yissum Research Development Company Of The Hebrewuniversityofjerusalem |
Methods, kits and pharmaceutical compositions for diagnosing, delaying onset of, preventing and/or treating osteoporosis
|
JP2008503206A
(ja)
|
2004-05-25 |
2008-02-07 |
日立化成工業株式会社 |
癌感受性を測定する方法
|
US20080287309A1
(en)
|
2004-07-10 |
2008-11-20 |
Alexion Pharmaceuticals, Inc. |
Methods for Discovering Antibodies Specific to Cancer Cells and Antibodies Discovered Thereby
|
US20090162350A1
(en)
|
2004-08-12 |
2009-06-25 |
Alexander Abbas |
Novel composition and methods for the treatment of immune related disease
|
TWI309240B
(en)
|
2004-09-17 |
2009-05-01 |
Hoffmann La Roche |
Anti-ox40l antibodies
|
AR051444A1
(es)
|
2004-09-24 |
2007-01-17 |
Centocor Inc |
Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos
|
WO2006045318A2
(en)
|
2004-10-27 |
2006-05-04 |
Aarhus Universitet |
Diagnosis and treatment of immune-related diseases
|
CA2586201A1
(en)
|
2004-11-03 |
2006-05-11 |
Almac Diagnostics Limited |
Transcriptome microarray technology and methods of using the same
|
WO2008109782A2
(en)
|
2007-03-06 |
2008-09-12 |
Cedars-Sinai Medical Center |
Diagnosis of inflammatory bowel disease in children
|
AU2005314089B2
(en)
|
2004-12-08 |
2011-03-03 |
Cedars-Sinai Medical Center |
Methods for diagnosis and treatment of Crohn's disease
|
MX2007008506A
(es)
|
2005-01-13 |
2010-05-17 |
Progenika Biopharma Sa |
Metodos y productos para genotipificacion in vitro.
|
US8110347B2
(en)
|
2005-04-15 |
2012-02-07 |
Canimguide Therapeutics Ab |
Diagnostic method for detecting cancer by measuring amount of cytokine like IL-6
|
WO2006116721A1
(en)
|
2005-04-28 |
2006-11-02 |
Hitachi Chemical Research Center, Inc. |
Ex vivo gene expression in whole blood as a model of assessment of individual variation to dietary supplements
|
US7531637B2
(en)
*
|
2005-05-06 |
2009-05-12 |
Zymogenetics, Inc. |
IL-31 monoclonal antibodies
|
WO2007143231A2
(en)
*
|
2006-01-10 |
2007-12-13 |
Zymogenetics, Inc. |
Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists
|
WO2006122187A2
(en)
|
2005-05-10 |
2006-11-16 |
Biogen Idec Ma Inc. |
Treating and evaluating inflammatory disorders
|
ES2301280A1
(es)
|
2005-05-16 |
2008-06-16 |
Fina Biotech S.L.U. |
Metodo para diagnosticar la enfermedad de alzheimer.
|
US20090317388A1
(en)
*
|
2005-05-25 |
2009-12-24 |
Linda Burkly |
Tl1a in treatment of disease
|
US7700739B2
(en)
|
2005-06-30 |
2010-04-20 |
Abbott Laboratories |
IL-12/p40 binding proteins
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
BRPI0617057A2
(pt)
|
2005-08-30 |
2011-07-12 |
Univ Miami |
anticorpo isolado, toxina especìfica para receptor de fator de necrose tumoral 25 (tnfr25), método para ativar o receptor de fator de necrose tumoral 25 (tnfr25), método para inibir a sinalização do receptor de fator de necrose tumoral 25 (tnfr25) numa célula, vacina antitumoral, método para imunizar um paciente contra tumor, método para tratar cáncer num paciente, método para tratar e/ou prevenir inflamação intestinal, composição terapêutica para a facilitação de um transplante de órgão, método para transplantar um tecido de um doador para um hospedeiro, método para inibir a expressão clonal de uma população de células t cd8 cognatas, método para tratar e/ou prevenir inflamação pulmonar, antagonista de tnfr25 isolado, composição e vetor de expressão
|
WO2007025989A2
(en)
|
2005-09-02 |
2007-03-08 |
Innogenetics N.V. |
Nucleic acid variants in the toll like receptor genes associated with altered innate immunity
|
US7935482B2
(en)
|
2005-09-27 |
2011-05-03 |
Source Precision Medicine, Inc. |
Gene expression profiling for identification monitoring and treatment of rheumatoid arthritis
|
US8234129B2
(en)
|
2005-10-18 |
2012-07-31 |
Wellstat Vaccines, Llc |
Systems and methods for obtaining, storing, processing and utilizing immunologic and other information of individuals and populations
|
US20090258848A1
(en)
|
2005-12-06 |
2009-10-15 |
The Johns Hopkins University |
Biomarkers for inflammatory bowel disease
|
US20070161031A1
(en)
|
2005-12-16 |
2007-07-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Functional arrays for high throughput characterization of gene expression regulatory elements
|
WO2007112059A2
(en)
|
2006-03-23 |
2007-10-04 |
Edrich Health Technologies , Inc. |
Vascular anastomotic staplers
|
EP2005175B1
(en)
|
2006-04-07 |
2011-07-27 |
Hitachi Chemical Company, Ltd. |
Enhanced t cell receptor-mediated tumor necrosis factor superfamily and chemokine mrna expression in peripheral blood leukocytes in patients with crohn's disease
|
US20100041600A1
(en)
|
2006-06-09 |
2010-02-18 |
Russel James A |
Interferon gamma polymorphisms as indicators of subject outcome in critically ill subjects
|
MX363905B
(es)
|
2006-06-12 |
2019-04-08 |
Aptevo Res & Development Llc |
Proteinas de union multivalentes monocatenarias con funcion efectora.
|
EP2044118A2
(en)
|
2006-06-13 |
2009-04-08 |
Zymogenetics, Inc. |
Il-17 and il-23 antagonists and methods of using the same
|
CA2658563A1
(en)
|
2006-07-26 |
2008-01-31 |
Genizon Biosciences Inc. |
Crohn disease susceptibility gene
|
US7993832B2
(en)
|
2006-08-14 |
2011-08-09 |
Xdx, Inc. |
Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
|
WO2008028031A2
(en)
|
2006-08-30 |
2008-03-06 |
Centocor, Inc. |
Markers and methods for assessing and treating ulcerative colitis and related disorders using a 43 gene panel
|
EP2639318B1
(en)
|
2006-09-11 |
2015-04-08 |
Celera Corporation |
Genetic polymorphisms associated with Psoriasis, methods of detection and uses thereof
|
AU2007300295A1
(en)
|
2006-09-25 |
2008-04-03 |
Boehringer Ingelheim International Gmbh |
Compounds which modulate the CB2 receptor
|
WO2008048902A2
(en)
|
2006-10-13 |
2008-04-24 |
Cedars-Sinai Medical Center |
Methods of using single nucleotide polymorphisms in the il23r gene to predict or diagnose inflammatory bowel disease
|
WO2008048986A2
(en)
|
2006-10-17 |
2008-04-24 |
Children's Hospital Medical Center |
Gene array technique for predicting response in inflammatory bowel diseases
|
US20100098721A1
(en)
|
2006-10-18 |
2010-04-22 |
St. Jude Children's Reseach Hospital |
Methods and compositions for preparing a universal influenza vaccine
|
US20100291551A1
(en)
|
2006-11-17 |
2010-11-18 |
Genizon Biosciences Inc. |
Genemap of the human associated with crohn's disease
|
US20080131887A1
(en)
|
2006-11-30 |
2008-06-05 |
Stephan Dietrich A |
Genetic Analysis Systems and Methods
|
US20090018031A1
(en)
|
2006-12-07 |
2009-01-15 |
Switchgear Genomics |
Transcriptional regulatory elements of biological pathways tools, and methods
|
US20090186034A1
(en)
|
2006-12-19 |
2009-07-23 |
Genetech, Inc. |
Gene expression markers for inflammatory bowel disease
|
US7691980B2
(en)
|
2007-01-09 |
2010-04-06 |
Bio-Rad Laboratories, Inc. |
Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
|
US9896511B2
(en)
|
2007-01-10 |
2018-02-20 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease comprising administering such antibodies
|
US20110217310A1
(en)
|
2007-01-10 |
2011-09-08 |
Siegel Richard M |
Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology
|
US20100021917A1
(en)
|
2007-02-14 |
2010-01-28 |
Cedars-Sinai Medical Center |
Methods of using genes and genetic variants to predict or diagnose inflammatory bowel disease
|
US20100190162A1
(en)
|
2007-02-26 |
2010-07-29 |
Cedars-Sinai Medical Center |
Methods of using single nucleotide polymorphisms in the tl1a gene to predict or diagnose inflammatory bowel disease
|
US20150337378A1
(en)
|
2007-02-28 |
2015-11-26 |
Cedars-Sinai Medical Center |
Methods of diagnosis and treatment of inflammatory bowel disease
|
US20100055700A1
(en)
|
2007-02-28 |
2010-03-04 |
Cedars-Sinai Medical Center |
Role of il-12, il-23 and il-17 receptors in inflammatory bowel disease
|
WO2010039931A2
(en)
|
2008-10-01 |
2010-04-08 |
Cedars-Sinai Medical Center |
Methods of using il17rd and il23-il17 pathway genes to diagnose crohn's disease
|
EP2132342A1
(en)
|
2007-03-02 |
2009-12-16 |
Université de Liège |
A method for determining the genotype at the crohn's disease locus
|
EP2132338A1
(en)
|
2007-03-06 |
2009-12-16 |
Eesti Biokeskus |
A method to determine single nucleotide polymorphisms and mutations in nucleic acid sequence
|
WO2008112990A2
(en)
|
2007-03-15 |
2008-09-18 |
Cedars-Sinai Medical Center |
Methods of diagnosis and treatment of crohn's disease
|
WO2008116150A2
(en)
|
2007-03-21 |
2008-09-25 |
Cedars-Sinai Medical Center |
Ileal pouch-anal anastomosis (ipaa) factors in the treatment of inflammatory bowel disease
|
WO2008134569A2
(en)
|
2007-04-26 |
2008-11-06 |
Cedars-Sinai Medical Center |
Diagnosis and treatment of inflammatory bowel disease in the puerto rican population
|
US20100144903A1
(en)
|
2007-05-04 |
2010-06-10 |
Cedars-Sinai Medical Center |
Methods of diagnosis and treatment of crohn's disease
|
US8153443B2
(en)
|
2007-05-10 |
2012-04-10 |
Cedars-Sinai Medical Center |
Characterization of the CBir1 antigenic response for diagnosis and treatment of Crohn's disease
|
US20150086567A1
(en)
|
2011-03-25 |
2015-03-26 |
Cedars-Sinai Medical Center |
Role of ifng methylation in inflammatory bowel disease
|
WO2011088380A1
(en)
|
2010-01-15 |
2011-07-21 |
Cedars-Sinai Medical Center |
Methods of using fut2 genetic variants to diagnose crohn's disease
|
EP2068926A4
(en)
|
2007-05-18 |
2012-08-08 |
Medimmune Llc |
IL-9 IN FIBROTIC AND INFLAMMATORY DISEASES
|
WO2012135142A1
(en)
|
2011-03-25 |
2012-10-04 |
Cedars-Sinai Medical Center |
Methods of diagnosing ulcerative colitis and crohn's disease
|
WO2010083234A1
(en)
|
2009-01-13 |
2010-07-22 |
Cedars-Sinai Medical Center |
Methods of using smad3 and jak2 genetic variants to diagnose and predict inflammatory bowel disease
|
US20150376707A1
(en)
|
2007-05-18 |
2015-12-31 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating inflammatory bowel disease
|
US20120190698A1
(en)
|
2011-01-25 |
2012-07-26 |
Cedars-Sinai Medical Center |
Methods of predicting thiopurine response
|
US9305137B1
(en)
|
2007-05-18 |
2016-04-05 |
Cedars-Sinai Medical Center |
Methods of identifying the genetic basis of a disease by a combinatorial genomics approach, biological pathway approach, and sequential approach
|
CA2695897A1
(en)
|
2007-08-09 |
2009-02-12 |
University Of Otago |
Method of identifying individuals at risk of thiopurine drug resistance and intolerance
|
CN105861664A
(zh)
|
2007-09-26 |
2016-08-17 |
生命科技临床服务实验室公司 |
使用祖先数据进行基因组分析的方法和系统
|
WO2009052512A2
(en)
|
2007-10-19 |
2009-04-23 |
Cedars-Sinai Medical Center |
Methods of using genetic variants to diagnose and predict inflammatory bowel disease
|
UA104132C2
(en)
|
2007-11-13 |
2014-01-10 |
Тева Биофармасьютикалз Юесей, Инк. |
Humanized antibodies against tl1a
|
US7947451B2
(en)
|
2007-11-30 |
2011-05-24 |
Celera Corporation |
Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
|
CN101469270B
(zh)
|
2007-12-27 |
2012-08-22 |
牛斌 |
工业连续化塑料裂解器
|
US7773519B2
(en)
|
2008-01-10 |
2010-08-10 |
Nuova Systems, Inc. |
Method and system to manage network traffic congestion
|
WO2009092010A1
(en)
|
2008-01-18 |
2009-07-23 |
Gagnon Peter S |
Enhanced purification of phosphorylated and non-phosphorylated biomolecules by apatite chromatography
|
DK2257643T3
(en)
|
2008-02-19 |
2015-06-29 |
Philadelphia Children Hospital |
Identification of pediatric onset of inflammatory bowel disease-loco and methods of use thereof for diagnosis and treatment thereof
|
US20090299645A1
(en)
|
2008-03-19 |
2009-12-03 |
Brandon Colby |
Genetic analysis
|
WO2009143278A2
(en)
|
2008-05-20 |
2009-11-26 |
Cedars-Sinai Medical Center |
Methods of diagnosing and characterizing cannabinoid signaling in crohn's disease
|
US20110111418A1
(en)
|
2008-06-23 |
2011-05-12 |
Cedars-Sinai Medical Center |
Use of iron-related pathways and genes for treatment and diagnosis of parkinson's disease
|
US20100008934A1
(en)
|
2008-07-02 |
2010-01-14 |
Celera Corporation |
Genetic polymorphisms associated with autoinflammatory diseases, methods of detection and uses thereof
|
BRPI0917130A2
(pt)
|
2008-08-25 |
2015-12-01 |
Centocor Ortho Biotech Inc |
biomarcadores para tratamento anti-tnf de colite ulcerativa e transtornos relacionados
|
US20110136113A1
(en)
|
2008-08-27 |
2011-06-09 |
Sysmex Corporation |
Marker for detecting il-17-producing helper t cell, and method for detecting il-17-producing helper t cell
|
AU2009285585A1
(en)
|
2008-08-28 |
2010-03-04 |
Wyeth Llc |
Uses of IL-22, IL-17, and IL-1 family cytokines in autoimmune diseases
|
JP2010088432A
(ja)
|
2008-09-09 |
2010-04-22 |
Kansetsu Saisei Kenkyusho:Kk |
Tnf阻害薬治療による有効性・副作用発現に関する多型、およびその利用
|
EP2331575B1
(en)
|
2008-09-29 |
2014-05-28 |
Roche Glycart AG |
Antibodies against human il 17 and uses thereof
|
WO2010044923A1
(en)
|
2008-10-21 |
2010-04-22 |
Morehouse School Of Medicine |
Methods for haplotype determination by haplodissection
|
US20110189685A1
(en)
|
2008-10-22 |
2011-08-04 |
Cedars-Sinai Medical Center |
Methods of using jak3 genetic variants to diagnose and predict crohn's disease
|
AU2009314259B2
(en)
|
2008-11-11 |
2015-06-11 |
Nestec S.A. |
Methods for prediction of inflammatory bowel disease (IBD) using serologic markers
|
US20110229471A1
(en)
|
2008-11-26 |
2011-09-22 |
Cedars-Sinai Medical Center |
Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
|
US20170044615A1
(en)
|
2008-12-24 |
2017-02-16 |
Cedars-Sinai Medical Center |
METHODS OF PREDICTING MEDICALLY REFRACTIVE ULCERATIVE COLITIS (mrUC) REQUIRING COLECTOMY
|
WO2010075584A1
(en)
|
2008-12-24 |
2010-07-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing and predicting crohns disease from childhood hygiene and serological profiles
|
US9580752B2
(en)
|
2008-12-24 |
2017-02-28 |
Cedars-Sinai Medical Center |
Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy
|
EP2411412B1
(en)
|
2009-03-24 |
2015-05-27 |
Teva Biopharmaceuticals USA, Inc. |
Humanized antibodies against light and uses thereof
|
WO2010118210A1
(en)
|
2009-04-08 |
2010-10-14 |
Cedars-Sinai Medical Center |
Methods of predicting complication and surgery in crohn's disease
|
EP2960342A1
(en)
|
2009-04-14 |
2015-12-30 |
Nestec S.A. |
Inflammatory bowel disease prognostics
|
EP2419121B1
(en)
|
2009-04-17 |
2018-07-18 |
New York University |
Peptides targeting tnf family receptors and antagonizing tnf action, compositions, methods and uses thereof
|
JP2011004390A
(ja)
|
2009-05-18 |
2011-01-06 |
Canon Inc |
撮像装置、撮像システム、及び撮像装置の駆動方法
|
AU2010259022B2
(en)
|
2009-06-08 |
2016-05-12 |
Singulex, Inc. |
Highly sensitive biomarker panels
|
CA2765889A1
(en)
|
2009-06-24 |
2010-12-29 |
Opko Curna, Llc |
Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2
|
US20110033486A1
(en)
|
2009-07-20 |
2011-02-10 |
Abbas Alexander R |
Gene expression markers for crohn's disease
|
WO2011017120A1
(en)
|
2009-07-27 |
2011-02-10 |
Cedars-Sinai Medical Center |
Use of ccr9, ccl25, batf and il17/il23 pathway variants to diagnose and treat inflammatory bowel disease
|
SG178125A1
(en)
|
2009-08-03 |
2012-03-29 |
Univ Miami |
Method for in vivo expansion of t regulatory cells
|
WO2011071725A1
(en)
|
2009-12-07 |
2011-06-16 |
Boehringer Ingelheim International Gmbh |
Heterocyclic compounds containing a pyrrolopyridine or benzimidazole core
|
US20130012602A1
(en)
|
2010-01-13 |
2013-01-10 |
Cedars-Sinai Medical Center |
Methods of using znf365 genetic variants to diagnose crohn's disease
|
WO2011088306A1
(en)
|
2010-01-15 |
2011-07-21 |
Cedars-Sinai Medical Center |
Methods of using genetic variants to diagnose crohn's disease
|
WO2011106707A2
(en)
|
2010-02-26 |
2011-09-01 |
Human Genome Sciences, Inc. |
Antibodies that specifically bind to dr3
|
WO2011116111A1
(en)
|
2010-03-16 |
2011-09-22 |
Cedars-Sinai Medical Center |
Methods of using prdm1 genetic variants to prognose, diagnose and treat inflammatory bowel disease
|
EP2609117B1
(en)
|
2010-08-25 |
2015-09-16 |
F.Hoffmann-La Roche Ag |
Antibodies against il-18r1 and uses thereof
|
PL2616489T3
(pl)
|
2010-09-16 |
2017-07-31 |
Baliopharm Ag |
Przeciwciało anty-huTNFR1
|
US8766034B2
(en)
|
2010-09-22 |
2014-07-01 |
Cedars-Sinai Medical Center |
TL1A model of inflammation fibrosis and autoimmunity
|
EP2630495B1
(en)
|
2010-10-18 |
2017-02-08 |
Nestec S.A. |
Methods for determining anti-drug antibody isotypes
|
JO3375B1
(ar)
|
2010-11-08 |
2019-03-13 |
Regeneron Pharma |
أجسام مضادة بشرية للجين a1 الشبيه بعامل النخر الورمي (tl1a)
|
WO2012071436A1
(en)
|
2010-11-24 |
2012-05-31 |
Genentech, Inc. |
Method of treating autoimmune inflammatory disorders using il-23r loss-of-function mutants
|
US9902996B2
(en)
|
2011-02-11 |
2018-02-27 |
Cedars-Sinai Medical Center |
Methods of predicting the need for surgery in crohn's disease
|
RU2013142278A
(ru)
|
2011-02-17 |
2015-03-27 |
Нестек С.А. |
ТЕСТЫ ДЛЯ ДЕТЕКЦИИ АУТОАНТИТЕЛ К АНТИ-TNFα ЛЕКАРСТВЕННЫМ СРЕДСТВАМ
|
CA2830365A1
(en)
|
2011-03-25 |
2012-10-04 |
Cedars-Sinai Medical Center |
Role of ifng methylation in inflammatory bowel disease
|
EP2689036B1
(en)
|
2011-03-25 |
2017-12-20 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating intestinal granulomas and low bone density in inflammatory bowel disease
|
MX2013013329A
(es)
|
2011-05-20 |
2014-04-16 |
Us Government |
Bloqueo de interacciones de factor de necrosis tumoral como ligando 1a - receptor de muerte 3 (tl1a-dr3) para mejorar la patologia mediada por las celulas t y los anticuerpos para los mismos.
|
SG10201902706VA
(en)
*
|
2011-06-03 |
2019-04-29 |
Xoma Technology Ltd |
Antibodies specific for tgf-beta
|
WO2012174338A2
(en)
|
2011-06-15 |
2012-12-20 |
Glaxosmithkline Llc |
Method of selecting therapeutic indications
|
CN202109170U
(zh)
|
2011-06-21 |
2012-01-11 |
徐毓艺 |
多座旋转连接装置
|
US8478890B2
(en)
|
2011-07-15 |
2013-07-02 |
Damaka, Inc. |
System and method for reliable virtual bi-directional data stream communications with single socket point-to-multipoint capability
|
US20130129668A1
(en)
|
2011-09-01 |
2013-05-23 |
The Regents Of The University Of California |
Diagnosis and treatment of arthritis using epigenetics
|
EP2565277A1
(en)
|
2011-09-05 |
2013-03-06 |
Progenika Biopharma, S.A. |
Method for predicting radiographic severity in ankylosing spondylitis
|
CN104114577A
(zh)
*
|
2011-09-30 |
2014-10-22 |
特瓦制药澳大利亚私人有限公司 |
针对TL1a的抗体及其用途
|
SG11201401536QA
(en)
|
2011-10-21 |
2014-05-29 |
Nestec Sa |
Methods for improving inflammatory bowel disease diagnosis
|
WO2013074833A1
(en)
|
2011-11-16 |
2013-05-23 |
The Board Of Trustees Of The Leland Stanford Junior University |
Capture probe and assay for analysis of fragmented nucleic acids
|
EP3196210A1
(en)
|
2011-11-23 |
2017-07-26 |
Amgen, Inc |
Methods of treatment using an antibody against interferon gamma
|
US10233495B2
(en)
|
2012-09-27 |
2019-03-19 |
The Hospital For Sick Children |
Methods and compositions for screening and treating developmental disorders
|
AU2013371957B2
(en)
|
2013-01-02 |
2018-10-25 |
Ichnos Sciences SA |
Antibodies that bind to TL1A and their uses
|
CN103149371B
(zh)
|
2013-02-26 |
2015-12-23 |
哈药慈航制药股份有限公司 |
生物标记物在制备预测5-氨基水杨酸治疗溃疡性结肠炎的反馈响应药物中的应用
|
CA2902877A1
(en)
|
2013-03-13 |
2014-10-02 |
Jeffrey Boyington |
Prefusion rsv f proteins and their use
|
AU2014241162A1
(en)
|
2013-03-27 |
2015-10-22 |
Cedars-Sinai Medical Center |
Mitigation and reversal of fibrosis and inflammation by inhibition of TL1A function and related signaling pathways
|
JP6482533B2
(ja)
|
2013-05-17 |
2019-03-13 |
セダーズ−シナイ メディカル センター |
クローン病に関連するtnfsf15及びdcr3の変異体
|
WO2014186665A2
(en)
|
2013-05-17 |
2014-11-20 |
Cedars-Sinai Medical Center |
Distinct effects of ifn-gamma and il-17 on tl1a modulated inflammation and fibrosis
|
EP4105236A1
(en)
|
2013-07-19 |
2022-12-21 |
Cedars-Sinai Medical Center |
Anti-tl1a (tnfsf15) antibody for treatment of inflammatory bowel disease
|
CN105636648A
(zh)
|
2013-09-06 |
2016-06-01 |
雪松-西奈医学中心 |
用于抗tl1a疗法的系统、装置和方法
|
HUE049281T2
(hu)
|
2013-09-13 |
2020-09-28 |
Beigene Switzerland Gmbh |
Anti-PD1 antitestek, valamint terapeutikumként és diagnosztikumként történõ alkalmazásuk
|
TWI736515B
(zh)
|
2013-11-13 |
2021-08-21 |
美商輝瑞大藥廠 |
類腫瘤壞死因子之配體1a之專一性抗體及其組合物及用途
|
CA2947291A1
(en)
|
2014-05-02 |
2015-11-05 |
Teva Pharmaceutical Industries Ltd. |
Treatment of crohn's disease with delayed-release 6-mercaptopurine
|
CA2946317A1
(en)
|
2014-05-02 |
2015-11-05 |
Cedars-Sinai Medical Center |
Methods of predicting medically refractive ulcerative colitis (mruc) requiring colectomy
|
US20150376612A1
(en)
|
2014-06-10 |
2015-12-31 |
The General Hospital Corporation |
CCCTC-Binding Factor (CTCF) RNA Interactome
|
MY191428A
(en)
|
2014-11-14 |
2022-06-27 |
Hoffmann La Roche |
Antigen binding molecules comprising a tnf family ligand trimer
|
WO2016149282A1
(en)
|
2015-03-16 |
2016-09-22 |
Cedars-Sinai Medical Center |
Methods of treating inflammatory bowel disease with ifn-gamma therapy
|
JP2018512876A
(ja)
|
2015-04-22 |
2018-05-24 |
ミナ セラピューティクス リミテッド |
saRNA組成物および使用方法
|
CN107835694A
(zh)
|
2015-05-15 |
2018-03-23 |
西达-赛奈医疗中心 |
用于治疗炎症性肠病的模型、方法和组合物
|
TWI703158B
(zh)
|
2015-09-18 |
2020-09-01 |
美商希佛隆公司 |
特異性結合tl1a之抗體
|
WO2017077715A1
(en)
|
2015-11-02 |
2017-05-11 |
La Jolla Institute For Allergy & Immunology |
Method and medicament for treating airway and/or lung diseases
|
CR20180365A
(es)
|
2015-12-16 |
2018-09-28 |
Amgen Inc |
PROTEÍNAS DE UNIÓN AL ANTÍGENO BISPECÍFICO DE ANTI-TL1A/ANTI-TNF-a Y SUS USOS
|
CN109462996A
(zh)
|
2016-03-17 |
2019-03-12 |
西达-赛奈医疗中心 |
通过rnaset2诊断炎性肠病的方法
|
EA039084B1
(ru)
|
2016-05-09 |
2021-12-01 |
Бристол-Майерс Сквибб Компани |
Антитела к tl1a и их применения
|
MX2019000898A
(es)
|
2016-07-25 |
2019-07-01 |
Cephalon Inc |
Amortiguador de lavado de cromatografia de afinidad.
|
MY191324A
(en)
|
2016-10-26 |
2022-06-15 |
Cedars Sinai Medical Center |
Neutralizing anti-tl1a monoclonal antibodies
|